Highest-risk patients will be considered.
The Food and Drug Administration has now approved the use of blood plasma from people who have survived COVID-19 to treat the most serious cases of the disease until a vaccine or other treatment can be deployed.
Dr. Jeffrey Henderson, associate professor of medicine and molecular microbiology at the Washington University School of Medicine in St. Louis said, “The approach definitely has merit, and what’s remarkable about it is it’s not a new idea; it’s been with us for a good hundred years or longer.” Henderson is part of the nationwide network of doctors and researchers working on protocols to use plasma to treat COVID-19.
“I think we don’t know until we have experience and case reports with this particular disease whether it will be effective, but just based on its track record with a number of other viruses, I think it has a very good chance of working,” Henderson added.
According to the protocols of the FDA, doctors can request to treat patients with the plasma on a case-by-case basis, and those who are at greatest risk of dying are the only ones to be considered at this time. Doctors need to be in contact with the FDA for approvals.
As the Lord Leads, Pray with Us…
- For doctors who are treating the gravely ill virus patients to engage with the FDA about the possible use of the blood plasma for treatment.
- For researchers, doctors and serologists who continue to work on other treatment possibilities and, ultimately, a vaccine against coronavirus.
Sources: NBS News, Newsmax
